Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identification of a molecule that recognizes HIV in immune cells

05.06.2015

In collaboration with colleagues from California and New York, researchers of the Paul-Ehrlich-Institut have identified a cytosolic receptor which enables cells of the immune system to recognize HIV and to trigger an immune response. The findings of the researchers may be a useful tool for creating an effective endogenous immune response against HIV and helpful to boost vaccine responses. Cell reports on the results of this research work in its online edition of 04.06.2015.

Particular immune cells of the body called dendritic cells are in principle capable of recognizing HIV-1 as foreign invader. HIV-1, usually just referred to as HIV, causes the immune deficiency disease AIDS (acquired immunodeficiency syndrome).


Two HI-Viruses outside the cell (green).

Source: PEI

Up to now, it has been unclear how the cells identify the virus as "foreign". In collaboration with colleagues from the Sanford Burnham Medical Research Institute, La Jolla, California and the Icahn School of Medicine at Mount Sinai, New York, Dr Renate König, head of the research group "Cellular Aspects of Pathogen-Host Interactions" at the Paul-Ehrlich-Institut and her research team have discovered that polyglutamine binding protein 1 plays an important role in this mechanism.

They have demonstrated that this protein recognizes and binds to specific retroviral DNA. Although the genome of retroviruses, which also includes HIV, is normally present as RNA, it must first be transcribed into DNA, before it can integrate into the genome of the host cell. PQBP1 binds to the viral DNA and, moreover, binds to an additional protein called cyclic GMP-AMP synthase. It is not until this connection has been made that cGAS can activate a signal pathway which in turn activates the innate immune system and in turn, the specific immune system.

"With PQBP1, we have identified an important receptor which mediates the recognition of HIV by the cell and the immune system", as Dr König described the research results. Up to now, it was assumed that cGAS alone was able to recognize foreign DNA. The researchers were now able to identify an additional important module in this mechanism.

Without PQBP1, dendritic cells are unable to recognize HIV. This was shown by Dr König and colleagues by investigating blood samples taken from patients suffering from Renpenning syndrome. In patients with this neurodegenerative disorder, the gene for PQBP1 has mutated and the protein is therefore not functional. The retroviral DNA of these patients’ immune cells could not bind to the protein so in turn cGAS signaling is not activated.

In principle, dendritic cells harbor the mechanism described here, which permits the activation of an immune response after the contact with retroviral DNA. Thus, the identified mechanism may guide potential treatment approaches. As Dr König explained the possible benefit from the findings: "Activation of this mechanism by an adjuvant could improve the immune response against HIV in the body and could thus also be used in immune therapy".

Original publication

Yoh SM, Schneider M, Seifried J, Soonthomvacharin S, Akleh RE, Olivieri KC, De Jesus PD, Ruan de Castro CE, Ruiz PA, Germanaud D, des Portes V, García-Sastre A, König R, Chanda SK (2015): PQBP1 is a Proximal Sensor of HIV-1 DNA and Initiates cGAS-dependent Innate Immune Signaling.
Cell Jun 4 [Epub ahead of print].


The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.

The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://www.cell.com/cell/abstract/S0092-8674%2815%2900525-5 Publication (Abstract)
http://www.pei.de/EN/information/journalists-press/press-releases/2015/07-identi... This Press Release on the PEI-Website

Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>